Emergent BioSolutions Inc. (EBS) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
300 PROFESSIONAL DR GAITHERSBURG, MD 20879 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 111,700 | 642,600 | 576,100 | 621,300 | 167,800 | 112,200 | |||
| Cash and cash equivalent | 111,700 | 642,600 | 576,100 | 621,300 | 167,800 | 112,200 | |||
| Restricted cash and investments | 200 | 200 | 200 | 200 | |||||
| Receivables | 191,000 | 159,200 | 274,700 | 230,900 | 275,300 | 271,100 | |||
| Inventory, net of allowances, customer advances and progress billings | 328,900 | 350,700 | 350,800 | 307,000 | 222,500 | 205,800 | |||
| Inventory | 328,900 | 350,700 | 350,800 | 307,000 | 222,500 | 205,800 | |||
| Contract with customer, asset, after allowance for credit loss | 21,500 | ||||||||
| Deferred costs | 1,200 | ||||||||
| Other undisclosed current assets | 47,900 | 57,900 | 48,800 | 36,500 | 20,400 | 30,300 | |||
| Total current assets: | 679,500 | 1,210,400 | 1,272,100 | 1,195,900 | 686,200 | 620,800 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 382,800 | 817,600 | 800,100 | 644,100 | 542,300 | 510,200 | |||
| Intangible assets, net (including goodwill) | 566,600 | 947,000 | 829,500 | 929,800 | 979,500 | 1,021,300 | |||
| Goodwill | 218,200 | 224,900 | 266,700 | 266,600 | 259,700 | ||||
| Intangible assets, net (excluding goodwill) | 566,600 | 728,800 | 604,600 | 663,100 | 712,900 | 761,600 | |||
| Other noncurrent assets | 194,300 | 191,300 | 57,300 | 113,400 | 76,900 | 13,700 | |||
| Other undisclosed noncurrent assets | 42,400 | 63,400 | |||||||
| Total noncurrent assets: | 1,143,700 | 1,955,900 | 1,686,900 | 1,687,300 | 1,641,100 | 1,608,600 | |||
| TOTAL ASSETS: | 1,823,200 | 3,166,300 | 2,959,000 | 2,883,200 | 2,327,300 | 2,229,400 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 130,800 | 138,400 | 269,300 | 267,600 | 196,700 | 174,100 | |||
| Taxes payable | ✕ | ✕ | ✕ | 4,500 | |||||
| Employee-related liabilities | ✕ | ✕ | ✕ | 88,700 | 84,600 | 62,400 | 58,200 | ||
| Accounts payable | 112,200 | 103,500 | 128,900 | 136,100 | 94,800 | 80,700 | |||
| Accrued liabilities | 18,600 | 34,900 | 51,700 | 46,900 | 39,500 | 30,700 | |||
| Deferred revenue | 27,200 | 26,400 | ✕ | ||||||
| Debt | 413,700 | 957,300 | 12,900 | 10,100 | |||||
| Business combination, contingent consideration, liability | 2,700 | 3,400 | |||||||
| Other liabilities | 32,700 | 45,900 | 72,900 | 83,100 | 3,500 | ||||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 10,600 | ||
| Other undisclosed current liabilities | 44,200 | 57,500 | 31,600 | 33,800 | 3,200 | 5,600 | |||
| Total current liabilities: | 651,300 | 1,228,900 | 373,800 | 384,500 | 216,300 | 200,400 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 446,500 | 448,500 | 809,400 | 841,000 | 798,400 | 784,500 | |||
| Long-term debt, excluding current maturities | 446,500 | 448,500 | 809,400 | 841,000 | 798,400 | 784,500 | |||
| Liabilities, other than long-term debt | 76,100 | 101,200 | 156,800 | 210,700 | 134,200 | 179,200 | |||
| Accounts payable and accrued liabilities | 11,200 | ||||||||
| Deferred revenue | 4,700 | 55,500 | ✕ | ||||||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 85,600 | 62,500 | ||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 67,500 | ||
| Deferred income tax liabilities | 47,200 | 59,700 | 94,900 | 53,200 | ✕ | ||||
| Other liabilities | 28,900 | 41,500 | 52,700 | 67,800 | 48,600 | 38,000 | |||
| Business combination, contingent consideration, liability | 4,500 | 34,200 | |||||||
| Other undisclosed noncurrent liabilities | 89,900 | 54,400 | |||||||
| Total noncurrent liabilities: | 522,600 | 549,700 | 966,200 | 1,051,700 | 1,022,500 | 1,018,100 | |||
| Total liabilities: | 1,173,900 | 1,778,600 | 1,340,000 | 1,436,200 | 1,238,800 | 1,218,500 | |||
| Equity | |||||||||
| Equity, attributable to parent | 649,300 | 1,387,700 | 1,619,000 | 1,447,000 | 1,088,500 | 1,010,900 | |||
| Common stock | 100 | 100 | 100 | 100 | 100 | 100 | |||
| Treasury stock, value | (227,700) | (227,700) | (152,200) | (39,600) | (39,600) | (39,600) | |||
| Additional paid in capital | 904,400 | 873,500 | 829,400 | 784,900 | 716,100 | 688,600 | |||
| Accumulated other comprehensive income (loss) | (5,700) | 3,100 | (16,100) | (25,300) | (9,900) | (5,500) | |||
| Retained earnings (accumulated deficit) | (21,800) | 738,700 | 957,800 | 726,900 | 421,800 | 367,300 | |||
| Total equity: | 649,300 | 1,387,700 | 1,619,000 | 1,447,000 | 1,088,500 | 1,010,900 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,823,200 | 3,166,300 | 2,959,000 | 2,883,200 | 2,327,300 | 2,229,400 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,049,300 | 1,117,500 | 1,792,700 | 1,555,400 | 1,106,000 | 782,400 | ||
| Cost of revenue (Cost of Product and Service Sold) | (705,400) | (693,100) | (524,000) | (433,500) | (322,300) | |||
| Other undisclosed gross profit | (26,300) | (41,400) | ||||||
| Gross profit: | 317,600 | 383,000 | 1,792,700 | 1,031,400 | 672,500 | 460,100 | ||
| Operating expenses | (1,775,700) | (1,287,500) | (1,440,100) | (1,121,600) | (991,900) | |||
| Other undisclosed operating income (loss) | 731,700 | 734,500 | 524,000 | 433,500 | (370,300) | |||
| Operating income (loss): | (726,400) | (170,000) | 352,600 | 433,800 | 114,100 | 89,800 | ||
| Nonoperating expense | (4,800) | (49,000) | (38,200) | (26,600) | (36,700) | (8,300) | ||
| Other nonoperating income (expense) | 8,900 | (11,700) | (3,700) | 4,700 | 1,700 | 1,600 | ||
| Interest and debt expense | 2,500 | (37,300) | (34,500) | (31,300) | (38,400) | (9,900) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 31,300 | 38,400 | 9,900 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (728,700) | (256,300) | 279,900 | 407,200 | 77,400 | 81,500 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (2,500) | 37,300 | 34,500 | |||||
| Income (loss) from continuing operations before income taxes: | (731,200) | (219,000) | 314,400 | 407,200 | 77,400 | 81,500 | ||
| Income tax expense (benefit) | (29,300) | 7,400 | (83,500) | (102,100) | (22,900) | (18,800) | ||
| Income (loss) from continuing operations: | (760,500) | (211,600) | 230,900 | 305,100 | 54,500 | 62,700 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 230,900 | 305,100 | 54,500 | 62,700 | |
| Net income (loss) available to common stockholders, diluted: | (760,500) | (211,600) | 230,900 | 305,100 | 54,500 | 62,700 | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (760,500) | (211,600) | 230,900 | 305,100 | 54,500 | 62,700 | ||
| Other comprehensive loss | (400) | (1,800) | ||||||
| Comprehensive income (loss): | (760,500) | (211,600) | 230,900 | 305,100 | 54,100 | 60,900 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (8,800) | 19,200 | 9,200 | (15,400) | (4,000) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (769,300) | (192,400) | 240,100 | 289,700 | 50,100 | 60,900 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.